81523 Onc brst mrna 70 cnt 31 gene
Also known as: breast cancer 70+31 gene panel
Oncology (breast) messenger RNA analysis with count algorithm of 70 genes and 31 additional genes.
In Plain Language
comprehensive 101-gene breast cancer test
Clinical Context
Extended gene expression profiling of breast cancer combining 70-gene core with additional 31 genes for enhanced prognostication.
RVU Information
CPT 81523 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81523?
CPT 81523 (Onc brst mrna 70 cnt 31 gene) is a Pathology & Lab code. Oncology (breast) messenger RNA analysis with count algorithm of 70 genes and 31 additional genes.
Who uses CPT code 81523?
CPT 81523 is used by oncology, breast surgery, molecular pathology. Extended gene expression profiling of breast cancer combining 70-gene core with additional 31 genes for enhanced prognostication.
When is CPT 81523 used?
Extended gene expression profiling of breast cancer combining 70-gene core with additional 31 genes for enhanced prognostication.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.